By region, the global biosimilars market is segmented into Europe, North America, Asia, and the Rest of World (ROW). Europe is estimated to contribute 46% to the growth of the global market over the forecast period. The expected approval of multiple biosimilars for blockbuster drugs like Lantus, HUMIRA, Neulasta, Herceptin, and REMICADE, which are currently under review by the EMA, the resumption of paused research studies, and the launch of new biosimilars are driving the growth of the regional market.
Company Profiles
The biosimilars market report includes information on the key products and recent developments of leading vendors, including:
AbbVie Inc.: The company offers biosimilars under the brand Humira.
Amgen Inc.: The company offers biosimilar services such as extrapolation and clinical trials.
Biocon Ltd.: The company offers biosimilars such as Insulin Glargine, Rh-insulin, and Insulin Glargine Disposable Pen.
Biogen Inc.: The company offers biosimilars for Ophthalmology and Immunology.
Boehringer Ingelheim International GmbH
Celltrion Healthcare Co. Ltd.
Dr Reddys Laboratories Ltd.
F. Hoffmann La Roche Ltd.
To gain access to more vendor profiles available with Technavio, buy the report!
Market Dynamics
The market is driven by factors such as the price advantage of biosimilars over biologics, the patent expiry of major biologics, and government initiatives to increase the use of biosimilar medicines. However, the access barriers for biosimilars are hindering market growth.
Competitive Analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample
Market Segmentation
By product type, the market is segmented into monoclonal antibodies, insulin, human growth hormone, and others. The monoclonal antibodies segment accounted for the largest share of the market in 2022.
By geography, the market is segmented into Europe, North America, Asia, and the Rest of the World (ROW). Europe held the largest share of the market in 2022.
Related Reports:
The biosimilar monoclonal antibodies (mAbs) market size is expected to increase by USD 8.65 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 30.17%. The increasing prevalence of chronic diseases is notably driving the biosimilar monoclonal antibodies (mAbs) market growth, although factors such as the presence of stringent regulatory policies may impede the market growth.
The human insulin drugs market size in Brazil is expected to increase by USD 137.41 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%. The rising prevalence of diabetes in Brazil is notably driving the human insulin drugs market growth in Brazil, although factors such as the high cost of human insulin drugs may impede the market growth.
What are the key data covered in this biosimilars market report?
CAGR of the market during the forecast period.
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the biosimilars market size and contribution of the market in focus to the parent market.
Accurate predictions about upcoming trends and changes in consumer behavior.
Growth of the market industry across Europe, North America, Asia, and Rest of World (ROW).
Thorough analysis of the market's competitive landscape and detailed information about vendors.
Comprehensive analysis of factors that will challenge the growth of biosimilar market vendors.
Biosimilars Market Scope
Report Coverage
Details
Page number
172
Base year
2022
Historic period
2017-2021
Forecast period
2023-2027
Growth momentum & CAGR
Accelerate at a CAGR of 23%
Market growth 2023-2027
USD 42227.12 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
22.9
Regional analysis
Europe, North America, Asia, and Rest of World (ROW)
Performing market contribution
Europe at 46%
Key countries
US, Germany, UK, China, and Republic of Korea
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter Plc, Halozyme Therapeutics Inc, Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Product Type
Exhibit 06: Executive Summary ? Chart on Market Segmentation by Application
Exhibit 07: Executive Summary ? Chart on Incremental Growth
Exhibit 08: Executive Summary ? Data Table on Incremental Growth
Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global biosimilars market 2017 - 2021
Exhibit 18: Historic Market Size ? Data Table on Global biosimilars market 2017 - 2021 ($ million)
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or "the Company") for violations...
Escalade, Inc. , a leading manufacturer and distributor of sporting goods and indoor/outdoor recreational equipment, today announced that it will issue first quarter 2024 results before the market opens on Thursday, April 25, 2024.
A conference call...
Great Neck Realty Co. is marketing the intellectual property (the "Assets") of BOA Nutrition, Inc., ("Company" or "BOA"), an innovative sports nutrition and wellness company that specialized in producing oral aerosol energy supplements tailored to...
West Fraser Timber Co. Ltd. ("West Fraser" or the "Company") reported today the first quarter results of 2024 ("Q1-24"). All dollar amounts in this news release are expressed in U.S. dollars unless noted otherwise.
First Quarter Highlights?
Sales...
Modine , a diversified leader in thermal management technologies and solutions, officially marked the opening of a second facility in Sremska, Serbia, to manufacture coils for commercial and residential heat pump applications. Serbian Prime...